nanotech investing Nuvation Bio to Present New Quality-of-Life Data for IBTROZI® in Patients with ROS1-Positive Non-Small Cell Lung Cancer at ASCO 2026 Annual Meeting
nanotech investing Nuvation Bio to Collaborate with Thermo Fisher Scientific for U.S.-Based Manufacturing of IBTROZI® for ROS1-Positive Non-Small Cell Lung Cancer
nanotech investing Nuvation Bio Announces FDA Acceptance of Supplemental New Drug Application for IBTROZI® with Updated Duration of Response in Advanced ROS1-Positive Non-Small Cell Lung Cancer
nanotech investing Nuvation Bio Reports First Quarter 2026 Financial Results and Provides Business Update
nanotech investing Nuvation Bio Announces National Comprehensive Cancer Network® Adds Taletrectinib as Recommended Option to Clinical Practice Guidelines in Oncology for Central Nervous System Cancers
nanotech investing Nuvation Bio Announces IBTROZI® Showed Highly Durable Responses in Longer-Term Follow-up Data from Pivotal Studies Presented at AACR 2026
nanotech investing Nuvation Bio to Report First Quarter 2026 Financial Results and Provide Business Update on May 4, 2026
nanotech investing Nuvation Bio Announces Acquisition of Japan Rights to Safusidenib from Daiichi Sankyo
nanotech investing Eisai and Nuvation Bio Announce Marketing Authorisation Application for Taletrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer Validated by the European Medicines Agency
nanotech investing Nuvation Bio to Present Pivotal IBTROZI® Data in TKI-Naïve and TKI-Pretreated Patients with Advanced ROS1-Positive Non-Small Cell Lung Cancer at AACR 2026
nanotech investing Nuvation Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
nanotech investing Nuvation Bio to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 2, 2026
Standard Uranium Provides Drilling Update on the 2026 Drill Program at Flagship Davidson River Project - Announces Elevated Radioactivity in First Drill Hole
Goldgroup Closes Purchase of the San Francisco Gold Mine Acquiring 100% of Molimentales Del Noroeste, S.A. de C.V.
Bold Ventures Commences Summer Fieldwork at Burchell, Follows up at 111 Zone and JET Rare Earth Element System
